Ecstasy induced hepatitis mimicking viral hepatitis.
R S Dykhuizen, P W Brunt, Prescott Atkinson, John G. Simpson, C C Smith
Gut June 1, 1995 DOI: 10.1136/gut.36.6.939 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 3 |
| Population | Younger patients with unexplained jaundice after ingesting MDMA |
| Intervention | 3 |
| Topics | MDMA |
| Citations | 78 |
| Key findings | The authors report three cases of jaundice following MDMA ('ecstasy') ingestion and argue that ecstasy use should be considered when investigating unexplained jaundice in younger patients. They also describe complications associated with misuse of the drug, which they note was initially misrepresented as 'safer than alcohol'. |
Abstract
Three cases of jaundice after ingestion of 3,4-methylenedioxymetamphetamine (MDMA), known as 'ecstasy', are reported and the complications associated with the misuse of this drug, which was initially misrepresented as 'safer than alcohol' are described. Ingestion of 'ecstasy' should be considered when investigating unexplained jaundice in younger patients.